AAPM Foundation Spotlight: Opioid Reduction (102)

7:00 AM–8:30 AM Friday, February 28

Members of a consensus committee formed to address the care of those on long-term, high-dose opioids, especially “legacy patients,” will discuss methods and ethics of compassionate management with extensive audience participation. Criteria for maintaining vs. weaning, opioid use “gray zones,” the role of buprenorphine, i.a., will be discussed.

This is a non-CME event.

AAPM Foundation Opioid Reduction Consensus Project Introduction

Charles Argoff, MD

High Dose Patients: Taper or Maintain?

Ajay Manhapra

What Should Be Done About Dangerous Combinations

Michael Hooten, MD

When Is Referral Actually Abandonment

Mark Sullivan

Continue or Curtail, Consensual or Coercive: Who Decides?

Ed Covington

How to Taper

Mark Sullivan

Complex Persistent Dependence

Jane Ballantyne, MD FRCA

Fiscal Responsibility Versus Duties as Healers

Steven Stanos, DO

A Balancing Act: Tools to Help Taper

Jennifer Murphy, PhD

Learning Objectives:

  • Determine whether and how to reduce opioids.
  • Develop and implement a plan for comfortable opioid and sedative reduction.
  • Effectively manage those who, despite no opioid use disorder, respond poorly to both opioid escalation and reduction.